BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6785352)

  • 1. Analysis of the biosynthesis of HLA-DR glycoproteins in human malignant melanoma cell lines.
    Lloyd KO; Ng J; Dippold WG
    J Immunol; 1981 Jun; 126(6):2408-13. PubMed ID: 6785352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DR antigens of autologous melanoma and B lymphoblastoid cell lines: differences in glycosylation but not protein structure.
    Alexander S; Hubbard SC; Strominger JL
    J Immunol; 1984 Jul; 133(1):315-20. PubMed ID: 6609984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-dimensional gel analysis of the polypeptides precipitated by a polymorphic HLA-DR1,2,w6 monoclonal antibody: evidence for a third locus.
    De Kretser TA; Crumpton MJ; Bodmer JG; Bodmer WF
    Eur J Immunol; 1982 Jul; 12(7):600-6. PubMed ID: 6811289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invariant chain associates with HLA class II antigens via its extracytoplasmic region.
    Marks MS; Cresswell P
    J Immunol; 1986 Apr; 136(7):2519-25. PubMed ID: 3512715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of DR-like molecules on a marmoset Epstein-Barr virus-induced cell line using a monomorphic anti-human HLA-DR monoclonal antibody.
    Teillaud JL; Charron D; Goujet-Zalc C; Mahouy G
    Eur J Immunol; 1982 May; 12(5):446-8. PubMed ID: 6284521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biosynthesis and glycosylation of the invariant chain associated with HLA-DR antigens.
    Machamer CE; Cresswell P
    J Immunol; 1982 Dec; 129(6):2564-9. PubMed ID: 6982931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of two distinct light chains in HLA-DR-associated antigens by two-dimensional gel electrophoresis.
    de Kretser TA; Crumpton MJ; Bodmer JG; Bodmer WF
    Eur J Immunol; 1982 Mar; 12(3):214-21. PubMed ID: 6178597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biosynthesis and glycosylation of the carcinoma-associated antigen recognized by monoclonal antibody KS1/4.
    Fernsten PD; Pekny KW; Reisfeld RA; Walker LE
    Cancer Res; 1990 Aug; 50(15):4656-63. PubMed ID: 1695123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production and characterization of monoclonal antibodies recognizing the alpha-chain subunits of human ia alloantigens.
    Adams TE; Bodmer JG; Bodmer WF
    Immunology; 1983 Dec; 50(4):613-24. PubMed ID: 6197354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-dimensional gel analysis of a second family of class II molecules by polymorphic HLA-DR4,5, and w9 monoclonal antibodies.
    Maeda H; Hirata R; Okuyama M; Thompson A; Tohyama H
    J Immunol; 1984 May; 132(5):2478-84. PubMed ID: 6201545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of HLA-DR antigens by using monoclonal antibodies: recognition of conformational differences in biosynthetic intermediates.
    Shackelford DA; Lampson LA; Strominger JL
    J Immunol; 1981 Oct; 127(4):1403-10. PubMed ID: 6944380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A biochemical analysis of the secregation of HLA-DR heavy and light chains in a family studied by two-dimensional gel electrophoresis.
    Roux-Dosseto M; Rohner C; Birnbaum D; Bourgue F; Rebai N; Mawas C; Goridis C
    Ann Immunol (Paris); 1983; 134C(1):55-81. PubMed ID: 6407385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid nonlysosomal degradation of assembled HLA class II glycoproteins incorporating a mutant DR alpha-chain.
    Koppelman B; Cresswell P
    J Immunol; 1990 Oct; 145(8):2730-6. PubMed ID: 2212658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the MT3 molecule from HLA-DR4, 7, and w9 homozygous cell lines.
    Mukai R; Suzuki M; Yabe T; Hamaguchi H; Maeda H
    J Immunol; 1984 Dec; 133(6):3211-9. PubMed ID: 6436378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-reactions between mouse Ia and human HLA-D/DR antigens analyzed with monoclonal alloantibodies.
    Pierres M; Rebouah JP; Kourilsky FM; Dosseto M; Mercier P; Mawas C; Malissen B
    J Immunol; 1981 Jun; 126(6):2424-9. PubMed ID: 6785353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of HLA-DR antigens on leukaemic cells.
    Newman RA; Greaves MF
    Clin Exp Immunol; 1982 Oct; 50(1):41-50. PubMed ID: 6959750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies against MHC class II antigens elicited with a human non-T, non-B acute lymphoblastic leukemia cell line.
    Poláková K; Chorváth B; Sedlák J; Duraj J; Matoska J; Karpatová M
    Neoplasma; 1985; 32(6):641-8. PubMed ID: 3911080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical analysis of the polymorphism of three HLA-D region antigens.
    de Kretser T; Crumpton MJ; Bodmer JG; Bodmer WF
    Mol Biol Med; 1983 Jul; 1(1):59-76. PubMed ID: 6593560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of HLA-D-region antigens by two-dimensional gel electrophoresis. Molecular-genotyping.
    Charron DJ; McDevitt HO
    J Exp Med; 1980 Aug; 152(2 Pt 2):18s-36s. PubMed ID: 6931876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biosynthesis, glycosylation and intracellular processing of the neuroglandular antigen, a human melanoma-associated antigen.
    Dixon WT; Demetrick DJ; Ohyama K; Sikora LK; Jerry LM
    Cancer Res; 1990 Aug; 50(15):4557-65. PubMed ID: 2369731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.